Cargando…

Therapeutic Advances for Huntington’s Disease

Huntington’s disease (HD) is a progressive neurological disease that is inherited in an autosomal fashion. The cause of disease pathology is an expansion of cytosine-adenine-guanine (CAG) repeats within the huntingtin gene (HTT) on chromosome 4 (4p16.3), which codes the huntingtin protein (mHTT). Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Ashok, Kumar, Vijay, Singh, Kritanjali, Kumar, Sukesh, Kim, You-Sam, Lee, Yun-Mi, Kim, Jong-Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016861/ https://www.ncbi.nlm.nih.gov/pubmed/31940909 http://dx.doi.org/10.3390/brainsci10010043

Ejemplares similares

Advanced Glycation End Products (AGEs) May Be a Striking Link Between Modern Diet and Health
por: Gill, Vidhu, et al.
Publicado: (2019)

Bisphenols as a Legacy Pollutant, and Their Effects on Organ Vulnerability
por: Kim, Jong-Joo, et al.
Publicado: (2019)

Therapeutic Advances in the Management of Huntington’s Disease
por: Abdulrahman, Ganiy Opeyemi
Publicado: (2011)

Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006)

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease
por: Kim, Sangjune, et al.
Publicado: (2014)

Plants and phytochemicals for Huntington's disease
por: Choudhary, Sunayna, et al.
Publicado: (2013)

Genetic Heterogeneity of Beta Globin Mutations among Asian-Indians and Importance in Genetic Counselling and Diagnosis
por: Kumar, Ravindra, et al.
Publicado: (2013)

Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: An opinion
por: Kumar, Vishal, et al.
Publicado: (2021)

Sarcomeric Gene Variants and Their Role with Left Ventricular Dysfunction in Background of Coronary Artery Disease
por: Kumar, Surendra, et al.
Publicado: (2020)

Quantitative Gait Analysis in Patients with Huntington’s Disease
por: Pyo, Seon Jong, et al.
Publicado: (2017)

Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations
por: Vishwas, Sukriti, et al.
Publicado: (2021)

Huntington disease: Advances in the understanding of its mechanisms()
por: Gatto, Emilia M., et al.
Publicado: (2020)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

Recent Microscopy Advances and the Applications to Huntington’s Disease Research
por: Babi, Mouhanad, et al.
Publicado: (2022)

Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease
por: Maity, Shuvadeep, et al.
Publicado: (2022)

Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
por: Devi, Shweta, et al.
Publicado: (2021)

Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
por: Mees, Isaline, et al.
Publicado: (2023)

HDAC11: A novel inflammatory biomarker in Huntington’s disease
por: Kumar, Vishal, et al.
Publicado: (2022)

Huntington's disease: Molecular basis of pathology and status of current therapeutic approaches
por: Huang, Wen-Juan, et al.
Publicado: (2016)

Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington’s Disease
por: Simmons, Danielle A.
Publicado: (2017)

Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy
por: Jurcau, Anamaria, et al.
Publicado: (2022)

Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington’s disease
por: Saha, Sudeepto, et al.
Publicado: (2022)

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
por: Jurcau, Anamaria, et al.
Publicado: (2022)

In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease
por: Kohli, Harleen, et al.
Publicado: (2021)

New Avenues for the Treatment of Huntington’s Disease
por: Kim, Amy, et al.
Publicado: (2021)

Update of Rehabilitation in Huntington’s Disease: Narrative Review
por: Kim, Ki-Hong, et al.
Publicado: (2023)

Non-Cell Autonomous and Epigenetic Mechanisms of Huntington’s Disease
por: Kim, Chaebin, et al.
Publicado: (2021)

Proteotoxicity: A Fatal Consequence of Environmental Pollutants-Induced Impairments in Protein Clearance Machinery
por: Devi, Shweta, et al.
Publicado: (2021)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Predicting Prognosis of Psychosis in Huntington's Disease: Case Report and Review of Literature
por: Kar, Sujita Kumar, et al.
Publicado: (2017)

Huntington’s Disease Pathogenesis: Two Sequential Components
por: Hong, Eun Pyo, et al.
Publicado: (2021)

Oxidative Stress and Huntington’s Disease: The Good, The Bad, and The Ugly
por: Kumar, Amit, et al.
Publicado: (2016)

Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics
por: Jangid, Ashok Kumar, et al.
Publicado: (2023)

Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease
por: Velusamy, Thirunavukkarasu, et al.
Publicado: (2017)

Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington’s Disease
por: Mazarei, Gelareh, et al.
Publicado: (2015)

From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research
por: Jiang, Andrew, et al.
Publicado: (2023)

Therapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease
por: Labanca, Fabiana, et al.
Publicado: (2021)

Gene Therapy for Huntington’s Disease: The Final Strategy for a Cure?
por: Byun, Seulgi, et al.
Publicado: (2022)

Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay
por: Naren, Padmashri, et al.
Publicado: (2023)

Neuropsychiatric Disturbance in Huntington’s Disease: Approach to Management
por: Jay, J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d18v11t4al0lam0rpsscfpgi3p